Association of serum potassium concentration with mortality and ventricular arrhythmias in patients with acute myocardial infarction: A systematic review and meta-analysis
- PMID: 29473462
- DOI: 10.1177/2047487318759694
Association of serum potassium concentration with mortality and ventricular arrhythmias in patients with acute myocardial infarction: A systematic review and meta-analysis
Abstract
Background Challenging clinical practice guidelines that recommend serum potassium concentration between 4.0-5.0 mEq/L or ≥4.5 mEq/L in patients with acute myocardial infarction, recent studies found increased mortality risks in patients with a serum potassium concentration of ≥4.5 mEq/L. Studies investigating consequences of hypokalemia after acute myocardial infarction revealed conflicting results. Therefore, the aim of this systematic review and meta-analysis was to combine evidence from previous studies on the association of serum potassium concentration with both short and long-term mortality as well as the occurrence of ventricular arrhythmias. Design Systematic review and meta-analysis. Methods A structured search of MEDLINE and EMBASE databases yielded 23 articles published between 1990 and January 2017 that met the inclusion criteria. Study selection, data extraction and quality assessment were carried out by three reviewers. Random effects models were used to pool estimates across the included studies and sensitivity analyses were performed when possible. Results Twelve studies were included in the meta-analysis. Both pooled results from six studies investigating short-term mortality and from five studies examining long-term mortality revealed significantly increased risks in patients with serum potassium concentrations of <3.5 mEq/L, 4.5-<5.0 mEq/L and ≥5.0 mEq/L after acute myocardial infarction. In addition, a serum potassium concentration of <3.5 mEq/L was significantly associated with the occurrence of ventricular arrhythmias. Conclusions Mortality, both short and long term, and the occurrence of ventricular arrhythmias in patients with acute myocardial infarction seem to be negatively associated with hypokalemic serum potassium concentration. There is evidence for adverse consequences of serum potassium concentrations of ≥4.5 mEq/L. Due to the heterogeneity among existing studies, further research is necessary to confirm the need to change clinical practice guidelines.
Keywords: Myocardial infarction; arrhythmia; hyperkalemia; hypokalemia; meta-analysis; mortality.
Comment in
-
Serum potassium and acute coronary syndrome: In medio stat virtus.Eur J Prev Cardiol. 2018 Apr;25(6):574-575. doi: 10.1177/2047487318759689. Epub 2018 Feb 13. Eur J Prev Cardiol. 2018. PMID: 29436256 No abstract available.
Similar articles
-
Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry.BMC Cardiovasc Disord. 2017 Jul 24;17(1):198. doi: 10.1186/s12872-017-0635-x. BMC Cardiovasc Disord. 2017. PMID: 28738785 Free PMC article.
-
Serum potassium levels and mortality of patients with acute myocardial infarction: A systematic review and meta-analysis of cohort studies.Eur J Prev Cardiol. 2019 Jan;26(2):145-156. doi: 10.1177/2047487318780466. Eur J Prev Cardiol. 2019. PMID: 31060369
-
Serum Potassium Levels and Short-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.Angiology. 2016 Sep;67(8):729-36. doi: 10.1177/0003319715617074. Epub 2015 Dec 1. Angiology. 2016. PMID: 26626107
-
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).Circulation. 2008 Oct 14;118(16):1643-50. doi: 10.1161/CIRCULATIONAHA.108.778811. Epub 2008 Sep 29. Circulation. 2008. PMID: 18824643 Clinical Trial.
-
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies.Cardiovasc Drugs Ther. 2018 Apr;32(2):197-212. doi: 10.1007/s10557-018-6783-0. Cardiovasc Drugs Ther. 2018. PMID: 29679302
Cited by
-
Hyperkalemia Is Associated With Increased Mortality Among Unselected Cardiac Intensive Care Unit Patients.J Am Heart Assoc. 2019 Apr 2;8(7):e011814. doi: 10.1161/JAHA.118.011814. J Am Heart Assoc. 2019. PMID: 30922150 Free PMC article.
-
Effects of Serum Potassium on Mortality in Patients With ST-Elevation Myocardial Infarction.Cureus. 2024 May 26;16(5):e61126. doi: 10.7759/cureus.61126. eCollection 2024 May. Cureus. 2024. PMID: 38919213 Free PMC article.
-
Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models.Front Cardiovasc Med. 2021 Feb 3;8:620539. doi: 10.3389/fcvm.2021.620539. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33614751 Free PMC article. Review.
-
Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies.Nutr J. 2024 Jan 10;23(1):8. doi: 10.1186/s12937-023-00888-z. Nutr J. 2024. PMID: 38195532 Free PMC article.
-
Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention.Ther Adv Chronic Dis. 2023 Mar 4;14:20406223231158561. doi: 10.1177/20406223231158561. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 36895330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous